Healthcare Global Enterprises Ltd

Health.Global Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Healthcare Global Enterprises Ltd

₹ 545 -0.66%
12 Jun - close price
hcgoncology.com BSE: 539787 NSE: HCG
About

Healthcare Global Enterprises Ltd is engaged in setting up and managing hospitals and medical diagnostic services including scientific testing and consultancy services in the pharmaceutical and medical sector.[1]

Key Points

Service Offering
The Company is a provider of specialty healthcare focused on cancer and fertility. Under the “HCG” brand, it operates the largest cancer care network in India in terms of the total number of private cancer treatment centers licensed by the AERB. It also provides fertility treatment under our “Milann” brand. [1]

Website BSE NSE
  • Market Cap ₹ 7,600 Cr.
  • Current Price ₹ 545
  • High / Low ₹ 639 / 345
  • Stock P/E 430
  • Book Value ₹ 85.4
  • Dividend Yield 0.00 %
  • ROCE 6.54 %
  • ROE 1.49 %
  • Face Value ₹ 10.0
Edit ratios

Pros

Cons

  • Stock is trading at 6.38 times its book value
  • Though the company is reporting repeated profits, it is not paying out dividend
  • Company has low interest coverage ratio.
  • Company has a low return on equity of 2.97% over last 3 years.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Healthcare Healthcare Healthcare Services Hospital

Part of BSE Healthcare BSE SmallCap BSE Allcap Nifty Microcap 250 Nifty Total Market

Edit Columns
Loading peers table ...

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025
220 243 253 253 259 272 283 286 300 294 329 313 324
180 197 206 203 219 225 232 237 243 244 268 270 265
Operating Profit 40 46 47 50 40 48 50 49 57 50 62 42 59
OPM % 18% 19% 18% 20% 15% 17% 18% 17% 19% 17% 19% 14% 18%
-25 2 1 2 1 2 2 5 -12 10 10 -30 9
Interest 9 10 12 11 10 10 11 14 15 19 21 21 22
Depreciation 22 22 22 22 23 22 23 25 26 26 28 28 29
Profit before tax -16 16 14 19 8 18 18 15 4 15 23 -36 17
Tax % 14% 34% 21% 27% 47% 24% 25% 43% 146% 23% 22% 3% 40%
-18 11 11 14 4 14 14 9 -2 12 18 -37 10
EPS in Rs -1.29 0.78 0.79 1.02 0.30 0.98 0.98 0.62 -0.12 0.84 1.29 -2.68 0.73
Raw PDF

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
349 420 471 545 586 640 688 609 850 1,006 1,099 1,280
336 364 407 462 498 546 573 535 703 824 903 1,065
Operating Profit 13 56 64 83 88 94 116 74 147 181 196 215
OPM % 4% 13% 14% 15% 15% 15% 17% 12% 17% 18% 18% 17%
3 0 -1 7 19 13 -19 -129 65 7 1 -0
Interest 28 32 34 16 27 48 83 63 43 41 48 84
Depreciation 28 33 37 44 44 47 79 87 88 89 94 111
Profit before tax -40 -8 -9 29 37 13 -65 -205 81 58 55 20
Tax % -1% -69% -45% 34% 32% 42% -19% -7% 53% 30% 38% 82%
-40 -2 -5 19 25 7 -53 -192 38 40 34 4
EPS in Rs -5.79 -0.34 -0.56 2.27 2.86 0.82 -6.01 -15.28 2.75 2.89 2.44 0.25
Dividend Payout % 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0%
Compounded Sales Growth
10 Years: 12%
5 Years: 13%
3 Years: 15%
TTM: 16%
Compounded Profit Growth
10 Years: 25%
5 Years: 23%
3 Years: 10%
TTM: -58%
Stock Price CAGR
10 Years: %
5 Years: 35%
3 Years: 26%
1 Year: 44%
Return on Equity
10 Years: 1%
5 Years: 1%
3 Years: 3%
Last Year: 1%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Equity Capital 68 70 85 86 87 88 89 125 139 139 139 139
Reserves 192 202 435 459 552 557 526 798 959 1,006 1,049 1,052
254 311 194 218 264 422 827 481 349 347 740 1,118
99 107 136 159 210 337 328 169 197 237 259 295
Total Liabilities 614 690 850 923 1,112 1,404 1,769 1,575 1,644 1,730 2,188 2,604
371 405 431 442 492 547 914 745 774 788 938 1,038
CWIP 10 28 29 33 79 104 44 28 5 9 36 23
Investments 80 84 155 141 219 299 316 366 439 475 506 696
152 173 235 306 322 454 495 436 426 458 707 847
Total Assets 614 690 850 923 1,112 1,404 1,769 1,575 1,644 1,730 2,188 2,604

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
34 51 58 54 66 87 86 71 124 130 195 146
-7 -74 -86 -73 -185 -208 -116 -246 49 -138 -249 -347
-19 22 120 -14 91 66 -3 236 -41 -42 105 -42
Net Cash Flow 8 -1 92 -33 -27 -55 -32 61 132 -49 51 -243

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Debtor Days 54 56 54 67 79 83 81 88 69 77 68 75
Inventory Days 33 36 30 36 40 39 31 32 30 33 31 23
Days Payable 191 208 266 257 269 253 247 214 167 168 197 175
Cash Conversion Cycle -104 -116 -182 -154 -150 -131 -135 -94 -68 -59 -98 -77
Working Capital Days -33 -39 -46 -41 -23 -54 -72 105 30 39 20 41
ROCE % -2% 5% 5% 6% 7% 6% 4% 1% 5% 7% 7% 7%

Shareholding Pattern

Numbers in percentages

9 Recently
Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025
71.42% 71.39% 71.39% 71.37% 71.35% 71.30% 71.29% 71.28% 71.26% 71.23% 71.22% 71.22%
7.22% 7.27% 7.18% 6.37% 6.47% 6.29% 6.37% 6.74% 3.95% 4.30% 2.77% 2.44%
4.55% 4.02% 4.41% 5.53% 6.58% 7.94% 8.46% 8.52% 10.89% 11.64% 12.94% 12.48%
16.81% 17.32% 17.04% 16.71% 15.59% 14.49% 13.89% 13.45% 13.90% 12.84% 13.07% 13.86%
No. of Shareholders 23,01824,67228,70728,85825,93127,32727,28927,19526,52929,67032,82045,394

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

DRHP

Credit ratings

Concalls